1. Home
  2. Stock quotes
  3. Stock Blueprint Medicines Corporation
Blueprint Medicines Corporation logo

Blueprint Medicines Corporation BPMC

$ 92.03 1.46%
mail-toReport an Error

Quarterly report 2024-Q3
added 10-30-2024

report update icon

Country

 usaUSA

IPO year

 2015

Industry

 Biotechnology

Stock Exchange

 NASDAQ GLOBALSPB

CEO

 Mr. Jeffrey Albers

Employees in the company

 420

Shares

 60.6 M

Market Cap[1]

 $ 5.57 B

EBITDA (LTM)

 $ 14.8 M

P/E (LTM)

 -

P/S (LTM)

 -

EPS (LTM)

 -

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Sorrento Therapeutics Sorrento Therapeutics
SRNE
 		$ 0.27 -29.58 % $ 126 M Nasdaq Global Select Market usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
 		$ 1.47 -5.16 % $ 5.39 M Nasdaq Capital Market usaUSA
Orchard Therapeutics plc Orchard Therapeutics plc
ORTX
 		$ 4.93 1.02 % $ 90.8 M Nasdaq Global Select Market britainBritain
Coherus BioSciences Coherus BioSciences
CHRS
 		$ 0.68 -5.71 % $ 64 M Nasdaq Global Market usaUSA
Advaxis Advaxis
ADXS
 		$ 0.31 -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
Heat Biologics, Inc. Heat Biologics, Inc.
HTBX
 		$ 3.93 -5.76 % $ 99.8 M Nasdaq Capital Market usaUSA
La Jolla Pharmaceutical Company La Jolla Pharmaceutical Company
LJPC
 		$ 6.2 - $ 154 M Nasdaq Capital Market usaUSA
Zymeworks Zymeworks
ZYME
 		$ 6.42 - $ 404 M NYSE canadaCanada
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
 		$ 10.5 - $ 231 M Nasdaq Global Market usaUSA
Kadmon Holdings, Inc. Kadmon Holdings, Inc.
KDMN
 		$ 9.5 - $ 1.7 B Nasdaq Global Select Market usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
 		$ 2.58 -4.8 % $ 255 M Nasdaq Global Select Market usaUSA
Zosano Pharma Corporation Zosano Pharma Corporation
ZSAN
 		$ 0.56 7.23 % $ 2.72 M Nasdaq Global Select Market usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		$ 0.5 - $ 7.46 M Nasdaq Global Market israelIsrael
Acceleron Pharma Inc. Acceleron Pharma Inc.
XLRN
 		$ 179.68 - $ 10.9 B Nasdaq Global Market,SPB usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		$ 44.15 -0.23 % $ 916 M Nasdaq Capital Market usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
 		$ 0.32 - $ 23.9 M Nasdaq Global Select Market usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
 		$ 3.14 1.95 % $ 13.1 M Nasdaq Global Select Market chinaChina
Kiromic BioPharma Kiromic BioPharma
KRBP
 		$ 3.15 6.61 % $ 3.08 M Nasdaq Global Select Market usaUSA
Trillium Therapeutics Inc. Trillium Therapeutics Inc.
TRIL
 		$ 18.44 - $ 1.94 B Nasdaq Capital Market canadaCanada
Celyad Oncology SA Celyad Oncology SA
CYAD
 		$ 0.47 - $ 12.5 M Nasdaq Global Market belgiumBelgium

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.